Oxford Gene Technology Obtains CE-IVDR Certificates for FISH Products
According to the Oxford, UK-based company, the probes are important for patient management while treating hematological cancers and prenatal conditions.
In Brief This Week: Qiagen, LabCorp, Oxford Gene Technology, Quest, Hologic, PerkinElmer, and More
News items from the in vitro diagnostics industry for the week of Nov. 18, 2019.
Faced With New European IVD Regulations, Smaller Dx Firms Refocus Resources, Reassess Strategies
With the significant overhaul of the European regulatory landscape underway, some fear it may disproportionately affect small and medium-sized IVD companies.
FDA Clears Oxford Gene Technology FISH Probes
The FDA granted de novo classification for eight probes for detecting chromosomal rearrangements reported in acute myeloid leukemia and myelodysplastic syndromes.
Sysmex to Acquire Oxford Gene Technology
The acquisition allows Sysmex to enter the cytogenetics market and strengthens its technology base in molecular genetics, while expanding its life science business.